157 related articles for article (PubMed ID: 19827007)
1. Changes in the mRNA expression of osteoblast-related genes in response to beta(3)-adrenergic agonist in UMR106 cells.
Nuntapornsak A; Wongdee K; Thongbunchoo J; Krishnamra N; Charoenphandhu N
Cell Biochem Funct; 2010 Jan; 28(1):45-51. PubMed ID: 19827007
[TBL] [Abstract][Full Text] [Related]
2. Prolactin decreases expression of Runx2, osteoprotegerin, and RANKL in primary osteoblasts derived from tibiae of adult female rats.
Charoenphandhu N; Teerapornpuntakit J; Methawasin M; Wongdee K; Thongchote K; Krishnamra N
Can J Physiol Pharmacol; 2008 May; 86(5):240-8. PubMed ID: 18432284
[TBL] [Abstract][Full Text] [Related]
3. Prolactin directly enhances bone turnover by raising osteoblast-expressed receptor activator of nuclear factor kappaB ligand/osteoprotegerin ratio.
Seriwatanachai D; Thongchote K; Charoenphandhu N; Pandaranandaka J; Tudpor K; Teerapornpuntakit J; Suthiphongchai T; Krishnamra N
Bone; 2008 Mar; 42(3):535-46. PubMed ID: 18166509
[TBL] [Abstract][Full Text] [Related]
4. Prostate-specific antigen stimulates osteoprotegerin production and inhibits receptor activator of nuclear factor-kappaB ligand expression by human osteoblasts.
Yonou H; Horiguchi Y; Ohno Y; Namiki K; Yoshioka K; Ohori M; Hatano T; Tachibana M
Prostate; 2007 Jun; 67(8):840-8. PubMed ID: 17394194
[TBL] [Abstract][Full Text] [Related]
5. Inductive effects of dexamethasone on the mineralization and the osteoblastic gene expressions in mature osteoblast-like ROS17/2.8 cells.
Mikami Y; Omoteyama K; Kato S; Takagi M
Biochem Biophys Res Commun; 2007 Oct; 362(2):368-73. PubMed ID: 17707772
[TBL] [Abstract][Full Text] [Related]
6. Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts.
Fizazi K; Yang J; Peleg S; Sikes CR; Kreimann EL; Daliani D; Olive M; Raymond KA; Janus TJ; Logothetis CJ; Karsenty G; Navone NM
Clin Cancer Res; 2003 Jul; 9(7):2587-97. PubMed ID: 12855635
[TBL] [Abstract][Full Text] [Related]
7. [Regulation of receptor activator of nuclear factor kappaB ligand and osteoprotegerin expression by prostaglandin E2 in osteoblastic-like cells].
Wang BL; Zheng F; Qiu MC
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1992-6. PubMed ID: 19062743
[TBL] [Abstract][Full Text] [Related]
8. Zebrafish scales respond differently to in vitro dynamic and static acceleration: analysis of interaction between osteoblasts and osteoclasts.
Kitamura K; Takahira K; Inari M; Satoh Y; Hayakawa K; Tabuchi Y; Ogai K; Nishiuchi T; Kondo T; Mikuni-Takagaki Y; Chen W; Hattori A; Suzuki N
Comp Biochem Physiol A Mol Integr Physiol; 2013 Sep; 166(1):74-80. PubMed ID: 23632157
[TBL] [Abstract][Full Text] [Related]
9. Osteoclast inhibitory lectin (OCIL) inhibits osteoblast differentiation and function in vitro.
Nakamura A; Ly C; Cipetić M; Sims NA; Vieusseux J; Kartsogiannis V; Bouralexis S; Saleh H; Zhou H; Price JT; Martin TJ; Ng KW; Gillespie MT; Quinn JM
Bone; 2007 Feb; 40(2):305-15. PubMed ID: 17049328
[TBL] [Abstract][Full Text] [Related]
10. Expression of RANKL/OPG during bone remodeling in vivo.
Tanaka H; Mine T; Ogasa H; Taguchi T; Liang CT
Biochem Biophys Res Commun; 2011 Aug; 411(4):690-4. PubMed ID: 21771583
[TBL] [Abstract][Full Text] [Related]
11. The suppressive effect of myeloid Elf-1-like factor (MEF) in osteogenic differentiation.
Kim YJ; Kim BG; Lee SJ; Lee HK; Lee SH; Ryoo HM; Cho JY
J Cell Physiol; 2007 Apr; 211(1):253-60. PubMed ID: 17167770
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory T cells rapidly induce differentiation of human bone marrow stromal cells into mature osteoblasts.
Rifas L; Arackal S; Weitzmann MN
J Cell Biochem; 2003 Mar; 88(4):650-9. PubMed ID: 12577299
[TBL] [Abstract][Full Text] [Related]
13. Bradykinin potentiates cytokine-induced prostaglandin biosynthesis in osteoblasts by enhanced expression of cyclooxygenase 2, resulting in increased RANKL expression.
Brechter AB; Lerner UH
Arthritis Rheum; 2007 Mar; 56(3):910-23. PubMed ID: 17328065
[TBL] [Abstract][Full Text] [Related]
14. Induction of alkaline phosphatase activity by L-ascorbic acid in human osteoblastic cells: a potential role for CK2 and Ikaros.
Son E; Do H; Joo HM; Pyo S
Nutrition; 2007 Oct; 23(10):745-53. PubMed ID: 17664058
[TBL] [Abstract][Full Text] [Related]
15. Glucocorticoids promote development of the osteoblast phenotype by selectively modulating expression of cell growth and differentiation associated genes.
Shalhoub V; Conlon D; Tassinari M; Quinn C; Partridge N; Stein GS; Lian JB
J Cell Biochem; 1992 Dec; 50(4):425-40. PubMed ID: 1469073
[TBL] [Abstract][Full Text] [Related]
16. Development of the osteoblast phenotype in primary human osteoblasts in culture: comparison with rat calvarial cells in osteoblast differentiation.
Siggelkow H; Rebenstorff K; Kurre W; Niedhart C; Engel I; Schulz H; Atkinson MJ; Hüfner M
J Cell Biochem; 1999 Oct; 75(1):22-35. PubMed ID: 10462701
[TBL] [Abstract][Full Text] [Related]
17. Functional alpha1- and beta2-adrenergic receptors in human osteoblasts.
Huang HH; Brennan TC; Muir MM; Mason RS
J Cell Physiol; 2009 Jul; 220(1):267-75. PubMed ID: 19334040
[TBL] [Abstract][Full Text] [Related]
18. Circulating mesenchymal stem cells with abnormal osteogenic differentiation in patients with osteoporosis.
Dalle Carbonare L; Valenti MT; Zanatta M; Donatelli L; Lo Cascio V
Arthritis Rheum; 2009 Nov; 60(11):3356-65. PubMed ID: 19877060
[TBL] [Abstract][Full Text] [Related]
19. RNA interference of the BMPR-IB gene blocks BMP-2-induced osteogenic gene expression in human bone cells.
Singhatanadgit W; Salih V; Olsen I
Cell Biol Int; 2008 Nov; 32(11):1362-70. PubMed ID: 18773965
[TBL] [Abstract][Full Text] [Related]
20. Acidosis inhibits bone formation by osteoblasts in vitro by preventing mineralization.
Brandao-Burch A; Utting JC; Orriss IR; Arnett TR
Calcif Tissue Int; 2005 Sep; 77(3):167-74. PubMed ID: 16075362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
